Evolving patient-centric delivery models, expanding temperature-sensitive portfolios through an influx of new product developments, varying operating practices to fulfill regulatory guidelines, and increasing physical and cyber threats mean that crucial supply chain stability is now under severe threat. At the CCGF this year, we want to ensure that you find practical case studies to achieve the optimal equilibrium between patient centricity, operational and cost efficiency throughout your supply chain.

If these apply to your pharma company, make sure to download the End-to-End Temperature Controlled Mini Agenda to find out more!

If you would like a copy of the agenda sent directly to you, please contact us here.